Enzymatic pathways of the brain renin–angiotensin system: Unsolved problems and continuing challenges

The brain renin–angiotensin system continues to be enigmatic more than 40 years after the brain was first recognized to be a site of action of angiotensin II. This review focuses on the enzymatic pathways for the formation and degradation of the growing number of active angiotensins in the brain. A brief description and nomenclature of the peptidases involved in the processing of angiotensin peptides in the brain is given. Of primary interest is the array of enzymes that degrade radiolabeled angiotensins in receptor binding assays. This poses major challenges to studies of brain angiotensin receptors and it is debatable whether an accurate determination of brain angiotensin receptor binding kinetics has yet been made. The quandary facing the investigator of brain angiotensin receptors is the need to protect the radioligand from metabolic alteration while maintaining the characteristics of the receptors in situ. It is the tenet of this review that we have yet to fully understand the binding characteristics of brain angiotensin receptors and the extent of their distribution in the brain because of our inability to fully protect the angiotensins from metabolic alteration until equilibrium binding conditions can be attained.

• Publication year

  2007

• Venue

  Regulatory Peptides

• Publication date

  2007-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.regpep.2007.03.006PMID 17493693PMCID 7114358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preservation of 125‐I‐Angiotensin II in brain AT‐1 receptor binding assays

  2007cited by this paper
• Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain.

  2007influential reference
• Central Pressor Actions of Aminopeptidase-Resistant Angiotensin II Analogs: Challenging the Angiotensin III Hypothesis

  2007cited by this paper
• Enzymatic Properties of Human Aminopeptidase A: REGULATION OF ITS ENZYMATIC ACTIVITY BY CALCIUM AND ANGIOTENSIN IV

  2006cited by this paper
• Chymase: A New Pharmacologic Target in Cardiovascular Disease

  2006cited by this paper
• Evidence Supporting a Functional Role for Intracellular Renin in the Brain

  2006cited by this paper
• Enzymatic Properties of Human Aminopeptidase A

  2006cited by this paper
• Roles of brain angiotensins II and III in thirst and sodium appetite.

  2005cited by this paper
• Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles.

  2005cited by this paper
• The oxytocinase subfamily of M1 aminopeptidases.

  2005influential reference
• Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic Opportunities

  2005cited by this paper
• Rethinking the Renin-Angiotensin System and Its Role in Cardiovascular Regulation

  2005cited by this paper
• Lysosomal Cysteine Proteases: Structural Features and their Role in Apoptosis

  2005cited by this paper
• Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas.

  2005cited by this paper
• MEROPS: the peptidase database

  2005cited by this paper
• Aminopeptidase‐N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects

  2005influential reference
• EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor

  2005cited by this paper
• What’s new in the renin-angiotensin system?

  2004cited by this paper
• The zinc metallopeptidase family: new faces, new functions.

  2004cited by this paper
• Membrane bound members of the M1 family: more than aminopeptidases.

  2004influential reference
• Membrane-associated zinc peptidase families: comparing ACE and ACE2

  2004cited by this paper
• What’s new in the renin-angiotensin system?

  2004cited by this paper
• The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory.

  2004cited by this paper
• Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.

  2004cited by this paper
• The intracellular distribution and secretion of endopeptidases 24.15 (EC 3.4.24.15) and 24.16 (EC 3.4.24.16).

  2004cited by this paper
• Adjacent Expression of Renin and Angiotensinogen in the Rostral Ventrolateral Medulla Using a Dual-Reporter Transgenic Model

  2004cited by this paper
• Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.

  2004influential reference
• ACE2: from vasopeptidase to SARS virus receptor

  2004cited by this paper
• Aminopeptidase A is angiotensinase A

  2004cited by this paper
• Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.

  2003cited by this paper
• Human Leukocyte-derived Arginine Aminopeptidase

  2003cited by this paper
• In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase.

  2003cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Human Leukocyte-derived Arginine Aminopeptidase THE THIRD MEMBER OF THE OXYTOCINASE SUBFAMILY OF AMINOPEPTIDASES*

  2003cited by this paper
• Brain angiotensinergic activity: the state of our current knowledge.

  2003cited by this paper
• The angiotensin converting enzyme (ACE).

  2003cited by this paper
• Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

  2003cited by this paper
• Tonin expression in the rat brain and tonin-mediated central production of angiotensin II.

  2002cited by this paper
• The C-terminal domain, but not the interchain disulphide, is required for the activity and intracellular trafficking of aminopeptidase A.

  2002cited by this paper
• The prolyl oligopeptidase family

  2002cited by this paper
• Identification of prolylcarboxypeptidase as the cell matrix‐associated prekallikrein activator

  2002cited by this paper
• Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

  2002cited by this paper
• Proteases: a primer.

  2002cited by this paper
• Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.

  2002cited by this paper
• Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain

  2001cited by this paper
• Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase*

  2001influential reference
• Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation.

  2000cited by this paper
• Molecular characterization of a puromycin‐insensitive leucyl‐specific aminopeptidase, PILS‐AP

  2000influential reference
• Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues.

  2000cited by this paper
• Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.

  2000cited by this paper
• Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells.

  2000influential reference
• A Human Homolog of Angiotensin-converting Enzyme

  2000cited by this paper
• Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing.

  1999cited by this paper
• Aminopeptidase B (EC 3.4.11.6).

  1999cited by this paper
• Cathepsin A/protective protein: an unusual lysosomal multifunctional protein

  1999cited by this paper
• PC18, a Specific Aminopeptidase N Inhibitor, Induces Vasopressin Release by Increasing the Half-Life of Brain Angiotensin III

  1999cited by this paper
• Expression of protective protein in human tissue.

  1999cited by this paper
• Aminopeptidase A inhibitors as potential central antihypertensive agents.

  1999cited by this paper
• Angiotensin, thirst, and sodium appetite.

  1998cited by this paper
• Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells.

  1998cited by this paper
• Purification, Characterization, and Cloning of a Cytosolic Aspartyl Aminopeptidase*

  1998influential reference
• Angiotensin II in central nervous system physiology.

  1998cited by this paper
• Cellular carboxypeptidases

  1998influential reference
• Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.

  1998cited by this paper
• Serine Proteases in Rodent Hippocampus*

  1998cited by this paper
• Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells.

  1998influential reference
• Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15.

  1998cited by this paper
• Cathepsin E in the central nervous system.

  1998influential reference
• High levels of human chymase expression in the pineal and pituitary glands.

  1997cited by this paper
• Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX

  1997cited by this paper
• Thiol Activation of Endopeptidase EC 3.4.24.15

  1997cited by this paper
• Distribution of tonin- and kallikrein-like activities in rat brain.

  1997cited by this paper
• Determination of aminopeptidase X activity in tissues of normo- and hypertensive rats by capillary electrophoresis.

  1997cited by this paper
• Distinct Properties of Neuronal and Astrocytic Endopeptidase 3.4.24.16: A Study on Differentiation, Subcellular Distribution, and Secretion Processes

  1996cited by this paper
• The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A.

  1996cited by this paper
• Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain.

  1996cited by this paper
• Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

  1996cited by this paper
• Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function.

  1996cited by this paper
• Rat Brain Contains High Levels of Mannose-6-phosphorylated Glycoproteins Including Lysosomal Enzymes and Palmitoyl-Protein Thioesterase, an Enzyme Implicated in Infantile Neuronal Lipofuscinosis*

  1996cited by this paper
• Molecular Cloning and Expression of Rat Brain Endopeptidase 3.4.24.16 (*)

  1995cited by this paper
• Location and secretion of brain angiotensinogen.

  1995cited by this paper
• Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme

  1995cited by this paper
• Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells.

  1995cited by this paper
• Processing of the Precursors to Neurotensin and Other Bioactive Peptides by Cathepsin E (*)

  1995cited by this paper
• Interaction of Phe8 of Angiotensin II with Lys199 and His256 of AT1 Receptor in Agonist Activation (*)

  1995cited by this paper
• Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture.

  1995cited by this paper
• Properties of rat brain dipeptidyl aminopeptidases in the presence of detergents.

  1995cited by this paper
• Brain angiotensin receptor subtypes in the control of physiological and behavioral responses.

  1994cited by this paper
• Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.

  1994cited by this paper
• Degradation of angiotensin I to [des-Asp1]angiotensin I by a novel aminopeptidase in the rat hypothalamus.

  1994influential reference
• Dipeptidyl Aminopeptidase III of Guinea‐Pig Brain: Specificity for Short Oligopeptide Sequences

  1994cited by this paper
• Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.

  1993cited by this paper
• Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes.

  1993cited by this paper
• Human thimet oligopeptidase.

  1993cited by this paper
• Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families.

  1993influential reference
• A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

  1993cited by this paper
• Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells.

  1993cited by this paper
• Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II.

  1993cited by this paper
• Expression of cathepsin G-like and α1-antichymotrypsin-like proteins in reactive astrocytes

  1993cited by this paper
• Brain and pituitary angiotensin.

  1992influential reference

• In Vivo Multiplexed Analysis of Aminopeptidase Activities by Hyperpolarized Molecular Probes for Tumor Diagnostic Applications.

  2026cites this paper
• The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment

  2025cites this paper
• Bioactivity Profiling of Chemical Mixtures for Hazard Characterization

  2024cites this paper
• Structural basis of divergent substrate recognition and inhibition of human neurolysin

  2024cites this paper
• Correlational Study of Aminopeptidase Activities between Left or Right Frontal Cortex versus the Hypothalamus, Pituitary, Adrenal Axis of Spontaneously Hypertensive Rats Treated with Hypotensive or Hypertensive Agents

  2023cites this paper
• Mas receptor endocytosis and signaling in health and disease.

  2023cites this paper
• Current Pharmaceutical Biotechnology

  2022cites this paper
• Angiotensin-(1–7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage

  2022cites this paper
• Roles of Angiotensin III in the brain and periphery.

  2022cites this paper
• Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications

  2022cites this paper
• Angiotensin-(1-7) and Mas receptor in the brain

  2021influential citation
• Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer

  2021cites this paper
• Brain ACE2 Activation Following Brain Aminopeptidase A Blockade by Firibastat in Salt-dependent Hypertension.

  2021cites this paper
• Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19?

  2021influential citation
• Renin-Angiotensin-Aldosterone System

  2021cites this paper
• The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene

  2021cites this paper
• Glial Cells in the Schizophrenia Puzzle: Angiotensin II Role

  2021cites this paper
• Countering the classical renin-angiotensin system.

  2021cites this paper
• Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection

  2021cites this paper
• The role of peptidase neurolysin in neuroprotection and neural repair after stroke

  2020cites this paper
• Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice

  2020cites this paper
• The role of the brain renin-angiotensin system (RAS) in mild traumatic brain injury (TBI).

  2020cites this paper
• Severe food restriction activates the central renin angiotensin system

  2020cites this paper
• The possible role of a bacterial aspartate β-decarboxylase in the biosynthesis of alamandine.

  2020cites this paper
• Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension

  2020cites this paper
• Response to recent commentaries regarding the involvement of angiotensin‐converting enzyme 2 (ACE2) and renin‐angiotensin system blockers in SARS‐CoV‐2 infections

  2020cites this paper
• Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders.

  2019cites this paper
• Vascular Alterations in Mental Disorders: Focus in Angiotensin II Role

  2018cites this paper
• The depressor axis of the renin-angiotensin system and brain disorders: a translational approach.

  2018cites this paper
• Integrative Physiological Aspects of Brain RAS in Hypertension

  2018cites this paper
• Nicotine and the renin-angiotensin system.

  2018cites this paper
• Brain Angiotensin II Involvement in Chronic Mental Disorders.

  2017cites this paper
• Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension

  2017cites this paper
• How Is the Brain Renin-Angiotensin System Regulated?

  2017cites this paper
• Angiotensin converting enzymes in fish venom

  2017cites this paper
• Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer’s Disease

  2016cites this paper
• Preparation and preliminary characterization of recombinant neurolysin for in vivo studies.

  2016cites this paper
• Angiotensin-(1–7): beyond its central effects on blood pressure

  2015cites this paper
• Development of Local RAS in Cardiovascular/Body Fluid Regulatory Systems and Hypertension in Fetal Origins

  2014cites this paper
• The Importance of the RAS Interacting with the HGF/C-Met Receptor System in Hypertensive Type 2 Diabetes Mellitus

  2014cites this paper
• Protective axis of the renin-angiotensin system in the brain.

  2014cites this paper
• Update on the Renin-Angiotensin System

  2014cites this paper
• ANG-(3-4) inhibits renal Na+-ATPase in hypertensive rats through a mechanism that involves dissociation of ANG II receptors, heterodimers, and PKA.

  2014cites this paper
• p38 Mitogen-activated protein kinase is stimulated by both angiotensin II and angiotensin III in cultured rat astrocytes

  2014cites this paper
• Distribution of Non-AT1, Non-AT2 Binding of 125I-Sarcosine1, Isoleucine8 Angiotensin II in Neurolysin Knockout Mouse Brains

  2014cites this paper
• Effects of angiotensin (5-8) microinfusions into the ventrolateral periaqueductal gray on defensive behaviors in rats.

  2013cites this paper
• A Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases

  2013cites this paper
• Angiotensin II–Independent Angiotensin-(1–7) Formation in Rat Hippocampus: Involvement of Thimet Oligopeptidase

  2013cites this paper
• The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysin.

  2013cites this paper
• Angiotensin (5-8) modulates nociception at the rat periaqueductal gray via the NO-sGC pathway and an endogenous opioid.

  2013cites this paper
• Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice

  2013cites this paper
• Neuromodulatory role of angiotensin-(1-7) in the central nervous system.

  2013cites this paper
• The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases

  2012cites this paper
• Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension

  2012cites this paper
• Review article: the pathophysiological roles of the renin–angiotensin system in the gastrointestinal tract

  2012cites this paper
• ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

  2011influential citation
• A new tyrosine-specific chymotrypsin-like and angiotensin-degrading serine proteinase from Vipera lebetina snake venom.

  2011cites this paper
• Brain renin-angiotensin--a new look at an old system.

  2011cites this paper
• Identification of Membrane-bound Variant of Metalloendopeptidase Neurolysin (EC 3.4.24.16) as the Non-angiotensin Type 1 (Non-AT1), Non-AT2 Angiotensin Binding Site*

  2011cites this paper
• Distribution of a novel binding site for angiotensins II and III in mouse tissues

  2010cites this paper
• Physiological and pathophysiological functions of different angiotensins in the brain

  2010cites this paper
• Prolyl oligopeptidase in multiple sclerosis

  2010cites this paper
• Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain

  2010cites this paper
• Association of the Novel Non-AT1, Non-AT2 Angiotensin Binding Site with Neuronal Cell Death

  2010cites this paper
• Antagonists of the renin-angiotensin system and the prevention of obesity.

  2009cites this paper
• Human Coronaviruses 229E and NL63: Close Yet Still So Far

  2009cites this paper
• Angiotensin‐(1–7) through AT2 receptors mediates tyrosine hydroxylase degradation via the ubiquitin–proteasome pathway

  2009cites this paper
• Brain AT1 Angiotensin Receptor Subtype Binding: Importance of Peptidase Inhibition for Identification of Angiotensin II as Its Endogenous Ligand

  2009cites this paper
• A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes.

  2009cites this paper
• Characterization of the brain-specific non-AT(1), non-AT(2) angiotensin binding site in the mouse.

  2008cites this paper
• Distribution of cells expressing human renin-promoter activity in the brain of a transgenic mouse.

  2008influential citation
• Characterization of Carboxypeptidase A6, an Extracellular Matrix Peptidase*

  2008cites this paper
• The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain

  2008influential citation
• Brain angiotensin receptors and binding proteins

  2008cites this paper
• Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy

  2008influential citation
• Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides.

  2008influential citation
• The functional importance of the N-terminal region of human prolylcarboxypeptidase.

  2008cites this paper
• Central Pressor Actions of Aminopeptidase-Resistant Angiotensin II Analogs: Challenging the Angiotensin III Hypothesis

  2007cites this paper
• Challenging the Angiotensin III Hypothesis Central Pressor Actions of Aminopeptidase-Resistant Angiotensin II Analogs : Print

  2007cites this paper
• Patient Related Outcome Measures Dovepress Angiotensin Ii Type 1 Receptor Antagonists in the Treatment of Hypertension in Elderly Patients: Focus on Patient Outcomes

  year unknowncites this paper